SAM
MYOV

Shell Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Shell Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,074
Closed -$29K – 1464
2020
Q3 		$29K Hold
2,074
– – ﹤0.01% 1342
2020
Q2 		$43K Buy
+2,074
New +$28.2K ﹤0.01% 1275

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Shell Asset Management's MYOV Position: Q4 2020 in Review

Shell Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 2,074 shares — an estimated $29K sold.

Shell Asset Management first reported a position in MYOV in Q2 2020 and held it in 2 quarters. The position peaked at $43K in Q2 2020. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • Shell Asset Management reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Shell Asset Management sold 2,074 Myovant Sciences Ltd. shares in Q4 2020, an estimated $29K.
  • Shell Asset Management first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 2 quarters.
  • Shell Asset Management's Myovant Sciences Ltd. position peaked at $43K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on Shell Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.